Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
93 hedge funds and large institutions have $11.1M invested in Zomedica Corp. in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
11% more funds holding
Funds holding: 84 → 93 (+9)
1% less capital invested
Capital invested by funds: $11.1M → $11.1M (-$81.8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$519K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$490K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$103K |
| 4 |
State Street
Boston,
Massachusetts
|
+$51.2K |
| 5 |
WMA
West Michigan Advisors
Holland,
Michigan
|
+$49.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
Frazier Financial Advisors
Columbus,
Ohio
|
-$34.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.3K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$27.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$5.59K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$3.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
101
Hoey Investments
Coatesville,
Pennsylvania
| – | -$6 | -40 | Closed |
|
102
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$60 | +475 | +17% |
|
ZOM Hedge Fund Activity: Q4 2024 in Review
93 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2024, worth a combined $11.1M — down 0.73% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ZOM positions and 9 closed out — a net gain of 10 holders — while 17 added to existing stakes and 9 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $519K. The largest seller was Frazier Financial Advisors, exiting entirely with an estimated $34.3K sold.
- 93 institutional investors held Zomedica Corp. (ZOM) as of Q4 2024, up from 84 in Q3 2024.
- Funds reported $11.1M of Zomedica Corp. stock for Q4 2024, down 0.73% quarter-over-quarter.
- 19 funds opened new Zomedica Corp. positions in Q4 2024 and 9 closed out, a net change of +10 holders.
- The largest Zomedica Corp. buyer in Q4 2024 was Renaissance Technologies, an estimated $519K added.
- The largest Zomedica Corp. seller in Q4 2024 was Frazier Financial Advisors, an estimated $34.3K sold.
Based on aggregated 13F filings for Q4 2024.